Lifevantage Ownership
LFVN Stock | USD 6.78 0.43 5.96% |
Shares in Circulation | First Issued 2000-03-31 | Previous Quarter 12.6 M | Current Value 13 M | Avarage Shares Outstanding 9.3 M | Quarterly Volatility 6.3 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Lifevantage |
Lifevantage Stock Ownership Analysis
About 17.0% of the company outstanding shares are owned by corporate insiders. The book value of Lifevantage was now reported as 2.11. The company last dividend was issued on the 31st of May 2024. Lifevantage had 1:7 split on the 19th of October 2015. LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. Lifevantage operates under Packaged Foods classification in the United States and is traded on NASDAQ Exchange. It employs 259 people. To find out more about Lifevantage contact Steven Fife at 801 432 9000 or learn more at https://www.lifevantage.com.Besides selling stocks to institutional investors, Lifevantage also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Lifevantage's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Lifevantage's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Lifevantage Quarterly Liabilities And Stockholders Equity |
|
Lifevantage Insider Trades History
About 17.0% of Lifevantage are currently held by insiders. Unlike Lifevantage's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Lifevantage's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Lifevantage's insider trades
Lifevantage Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Lifevantage is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lifevantage backward and forwards among themselves. Lifevantage's institutional investor refers to the entity that pools money to purchase Lifevantage's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | O'shaughnessy Asset Management Llc | 2023-12-31 | 58.5 K | State Street Corporation | 2023-12-31 | 46.6 K | Globeflex Capital, L.p. | 2023-12-31 | 41.8 K | Northern Trust Corp | 2023-12-31 | 36.3 K | Barclays Plc | 2023-12-31 | 30.4 K | Heron Bay Capital Management | 2023-12-31 | 22.3 K | Comprehensive Portfolio Management, Llc | 2024-03-31 | 21.7 K | T. Rowe Price Associates, Inc. | 2023-12-31 | 20.7 K | Ep Wealth Advisors, Inc. | 2023-12-31 | 19.4 K | Renaissance Technologies Corp | 2023-12-31 | 838.1 K | Vanguard Group Inc | 2023-12-31 | 462.2 K |
Lifevantage Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Lifevantage insiders, such as employees or executives, is commonly permitted as long as it does not rely on Lifevantage's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Lifevantage insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kristen Cunningham over two weeks ago Disposition of 3001 shares by Kristen Cunningham of Lifevantage subject to Rule 16b-3 | ||
Kristen Cunningham over two weeks ago Disposition of 2417 shares by Kristen Cunningham of Lifevantage at 6.185 subject to Rule 16b-3 | ||
Alissa Neufeld over three weeks ago Disposition of 4201 shares by Alissa Neufeld of Lifevantage at 6.185 subject to Rule 16b-3 | ||
Steven Fife over a month ago Disposition of 16550 shares by Steven Fife of Lifevantage at 6.0 subject to Rule 16b-3 | ||
Steven Fife over a month ago Disposition of 15107 shares by Steven Fife of Lifevantage at 6. subject to Rule 16b-3 | ||
Carl Aure over a month ago Disposition of 2401 shares by Carl Aure of Lifevantage subject to Rule 16b-3 | ||
Dayton Judd over two months ago Acquisition by Dayton Judd of 12396 shares of Lifevantage at 6.0 subject to Rule 16b-3 | ||
Julie Boyster over three months ago Disposition of 3430 shares by Julie Boyster of Lifevantage at 6.85 subject to Rule 16b-3 |
Lifevantage Corporate Filings
10Q | 2nd of May 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 30th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 16th of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 13th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifevantage. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Lifevantage Stock, please use our How to Invest in Lifevantage guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Lifevantage Stock analysis
When running Lifevantage's price analysis, check to measure Lifevantage's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifevantage is operating at the current time. Most of Lifevantage's value examination focuses on studying past and present price action to predict the probability of Lifevantage's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifevantage's price. Additionally, you may evaluate how the addition of Lifevantage to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Lifevantage's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lifevantage. If investors know Lifevantage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lifevantage listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.625 | Dividend Share 0.14 | Earnings Share 0.28 | Revenue Per Share 16.374 | Quarterly Revenue Growth (0.10) |
The market value of Lifevantage is measured differently than its book value, which is the value of Lifevantage that is recorded on the company's balance sheet. Investors also form their own opinion of Lifevantage's value that differs from its market value or its book value, called intrinsic value, which is Lifevantage's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lifevantage's market value can be influenced by many factors that don't directly affect Lifevantage's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lifevantage's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lifevantage is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lifevantage's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.